Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
New antibiotic, gepotidacin, shows 92% effectiveness against drug-resistant gonorrhea in trials.
Researchers have developed a new antibiotic, gepotidacin, which shows promise in treating drug-resistant gonorrhea.
In a Phase 3 trial, the pill was 92% effective, targeting key enzymes the bacteria need to survive.
If approved, it would be the first new class of antibiotic for gonorrhea in over two decades.
Though effective, challenges like limited funding and the rise of resistant strains highlight the need for continued research.
32 Articles
El nuevo antibiótico, la gepotidacina, muestra un 92% de eficacia frente a la gonorrea resistente a los fármacos en ensayos clínicos.